Hans‐Dirk Düngen

6.2k total citations · 2 hit papers
56 papers, 2.4k citations indexed

About

Hans‐Dirk Düngen is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hans‐Dirk Düngen has authored 56 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Cardiology and Cardiovascular Medicine, 12 papers in Complementary and alternative medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hans‐Dirk Düngen's work include Heart Failure Treatment and Management (41 papers), Cardiovascular Function and Risk Factors (32 papers) and Cardiovascular and exercise physiology (12 papers). Hans‐Dirk Düngen is often cited by papers focused on Heart Failure Treatment and Management (41 papers), Cardiovascular Function and Risk Factors (32 papers) and Cardiovascular and exercise physiology (12 papers). Hans‐Dirk Düngen collaborates with scholars based in Germany, United States and Serbia. Hans‐Dirk Düngen's co-authors include Burkert Pieske, Frank Edelmann, Rolf Wachter, Christoph Herrmann‐Lingen, Götz Gelbrich, Gerd Hasenfuß, Raoul Stahrenberg, Martin Halle, Markus Löffler and André Duvinage and has published in prestigious journals such as JAMA, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Hans‐Dirk Düngen

56 papers receiving 2.3k citations

Hit Papers

Effect of Spironolactone on Diastolic Function and Exerci... 2011 2026 2016 2021 2013 2011 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
    2013 523 citations Frank Edelmann, Rolf Wachter et al. profile →
  2. Exercise Training Improves Exercise Capacity and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction
    2011 451 citations Frank Edelmann, Götz Gelbrich et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans‐Dirk Düngen Germany 20 1.9k 458 294 211 184 56 2.4k
Justin M. Canada United States 21 1.3k 0.7× 353 0.8× 164 0.6× 488 2.3× 320 1.7× 73 2.0k
Peter Moritz Becher Germany 9 1.4k 0.7× 106 0.2× 214 0.7× 336 1.6× 165 0.9× 11 1.9k
Emeline M. Van Craenenbroeck Belgium 33 1.8k 0.9× 754 1.6× 133 0.5× 775 3.7× 453 2.5× 137 3.3k
Christian Schmied Switzerland 28 1.6k 0.8× 267 0.6× 102 0.3× 108 0.5× 217 1.2× 120 2.2k
Marco Giuseppe Del Buono Italy 27 2.0k 1.1× 266 0.6× 156 0.5× 517 2.5× 302 1.6× 125 3.1k
Martino Deidda Italy 26 972 0.5× 95 0.2× 201 0.7× 355 1.7× 194 1.1× 86 1.9k
Roman Leischik Germany 20 1.0k 0.5× 169 0.4× 83 0.3× 162 0.8× 132 0.7× 77 2.0k
Timothy J. Vittorio United States 20 642 0.3× 125 0.3× 151 0.5× 131 0.6× 120 0.7× 84 1.3k
Е. V. Shlyakhto Russia 24 907 0.5× 57 0.1× 279 0.9× 356 1.7× 249 1.4× 283 2.1k
Johan De Sutter Belgium 33 3.8k 2.0× 317 0.7× 239 0.8× 123 0.6× 132 0.7× 172 4.9k

Countries citing papers authored by Hans‐Dirk Düngen

Since Specialization
Citations

This map shows the geographic impact of Hans‐Dirk Düngen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Dirk Düngen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Dirk Düngen more than expected).

Fields of papers citing papers by Hans‐Dirk Düngen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans‐Dirk Düngen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Dirk Düngen. The network helps show where Hans‐Dirk Düngen may publish in the future.

Co-authorship network of co-authors of Hans‐Dirk Düngen

This figure shows the co-authorship network connecting the top 25 collaborators of Hans‐Dirk Düngen. A scholar is included among the top collaborators of Hans‐Dirk Düngen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans‐Dirk Düngen. Hans‐Dirk Düngen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Düngen, Hans‐Dirk, Frank Donath, Rainard Fuhr, et al.. (2023). Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes. American Journal of Cardiovascular Drugs. 23(2). 145–155. 9 indexed citations
2.
Boschmann, Michael, Lars Klug, Frank Edelmann, et al.. (2022). Glucose-Induced Hemodynamic and Metabolic Response of Skeletal Muscle in Heart Failure Patients with Reduced vs. Preserved Ejection Fraction—A Pilot Study. Journal of Cardiovascular Development and Disease. 9(12). 456–456. 1 indexed citations
3.
Peikert, Alexander, Muthiah Vaduganathan, Finnian R. Mc Causland, et al.. (2022). Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON‐HF. European Journal of Heart Failure. 24(5). 794–803. 19 indexed citations
4.
Böettcher, Michael, Hans‐Dirk Düngen, Frank Donath, et al.. (2022). Vericiguat in Combination with Short‐Acting Nitroglycerin in Patients With Chronic Coronary Syndromes: The Randomized, Phase Ib, VENICE Study. Clinical Pharmacology & Therapeutics. 111(6). 1239–1247. 9 indexed citations
5.
Correale, Michele, Stefano Coiro, Elena‐Laura Antohi, et al.. (2021). Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins?. Heart Failure Reviews. 27(4). 1147–1163. 8 indexed citations
6.
Jackson, Alice M., Pardeep S. Jhund, Inder S. Anand, et al.. (2021). Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction. European Heart Journal. 42(36). 3741–3752. 93 indexed citations
7.
Tanacli, Radu, Djawid Hashemi, Elvis Tahirović, et al.. (2020). Multilayer Myocardial Strain Improves the Diagnosis of Heart Failure with Preserved Ejection Fraction. ESC Heart Failure. 7(5). 3240–3245. 15 indexed citations
8.
Pavlović, Milan, Aleksandar Đorđević, Sabine Haßfeld, et al.. (2020). Left ventricular mechanics in patients with hematological malignancies before initiation of chemo- and radiotherapy. International journal of cardiac imaging. 37(3). 881–887. 2 indexed citations
9.
Chavanon, Mira‐Lynn, Simone Inkrot, Christine Zelenak, et al.. (2017). Regional differences in health-related quality of life in elderly heart failure patients: results from the CIBIS-ELD trial. Clinical Research in Cardiology. 106(8). 645–655. 5 indexed citations
10.
Edelmann, Frank, Anna Bobenko, Götz Gelbrich, et al.. (2017). Exercise Training in Diastolic Heart Failure (Ex-DHF): Rationale and Design of a Multicentre, Prospective, Randomized, Controlled, Parallel Group Trial. European Journal of Heart Failure. 19(8). 1067–1074. 35 indexed citations
11.
Scherbakov, Nadja, Anja Sandek, Tibor Szabó, et al.. (2015). Insulin Resistance in Heart Failure: Differences Between Patients with Reduced and Preserved Left Ventricular Ejection Fraction. European Journal of Heart Failure. 17(10). 1015–1021. 37 indexed citations
12.
Loncar, Goran, Verena Tscholl, Elvis Tahirović, et al.. (2015). Should Procalcitonin be Measured Routinely in Acute Decompensated Heart Failure?. Biomarkers in Medicine. 9(7). 651–659. 14 indexed citations
13.
Edelmann, Frank, Goetz Gelbrich, Tobias Daniel Trippel, et al.. (2015). Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF. JACC Heart Failure. 4(2). 140–149. 49 indexed citations
14.
Düngen, Hans‐Dirk, Simone Inkrot, Svetlana Apostolović, et al.. (2014). Heart Rate Following Short-Term Beta-Blocker Titration Predicts All-Cause Mortality in Elderly Chronic Heart Failure Patients: Insights from the CIBIS-ELD Trial. European Journal of Heart Failure. 16(8). 907–914. 25 indexed citations
15.
16.
Apostolović, Svetlana, Dragana Stanojević, Mitja Lainščak, et al.. (2013). Regional differences among female patients with heart failure from the Cardiac Insufficiency BIsoprolol Study in ELDerly (CIBIS-ELD). Cardiology Journal. 21(3). 265–272. 1 indexed citations
17.
Edelmann, Frank, Raoul Stahrenberg, Götz Gelbrich, et al.. (2011). Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction. Clinical Research in Cardiology. 100(9). 755–764. 89 indexed citations
18.
Loncar, Goran, Stephan von Haehling, Elvis Tahirović, et al.. (2011). Effect of beta blockade on natriuretic peptides and copeptin in elderly patients with heart failure and preserved or reduced ejection fraction: Results from the CIBIS-ELD trial. Clinical Biochemistry. 45(1-2). 117–122. 15 indexed citations
19.
Düngen, Hans‐Dirk, J. Vollert, Julia Searle, et al.. (2010). Autoantibodies Against Cardiac Troponin I in Patients with Congestive Heart Failure. European Journal of Heart Failure. 12(7). 668–675. 14 indexed citations
20.
Stahrenberg, Raoul, Frank Edelmann, Meinhard Mende, et al.. (2010). The Novel Biomarker Growth Differentiation Factor 15 in Heart Failure with Normal Ejection Fraction. European Journal of Heart Failure. 12(12). 1309–1316. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Justin M. Canada Breakdown of academic impact, for papers by Peter Moritz Becher Breakdown of academic impact, for papers by Emeline M. Van Craenenbroeck Breakdown of academic impact, for papers by Christian Schmied Breakdown of academic impact, for papers by Marco Giuseppe Del Buono Breakdown of academic impact, for papers by Martino Deidda Breakdown of academic impact, for papers by Roman Leischik Breakdown of academic impact, for papers by Timothy J. Vittorio Breakdown of academic impact, for papers by Е. V. Shlyakhto Breakdown of academic impact, for papers by Johan De Sutter
Rankless by CCL
2026